Focus on 2020 FDA approval! Bielcorp's VP/Board member Keith Nalepka has launched a global roll out of Actipatch products! Here's a review of the electoceutical market in 2019.......
The use of electroceuticals, rather than pharmaceuticals, to treat patients is a rising trend as seen already with the uptake of spinal cord stimulators for the treatment of chronic pain. Electroceuticals provide a more local, targeted and immediate treatment than that provided by traditional pharmaceuticals. Commercial uptake of disruptive technologies such as those listed in this article will be key to driving the future of bioelectronic medicine.
Nice post slopak! Thinking that with some degree of confidence we can finally expect to see rising sales revenues from Biel in 2020. We know that the 29,500 units recently ordered by Mundipharma and Pharmalink UAE should soon be be reflected...and will hopefully be the tip of the iceberg. The shareholder updates confirm that Biel has numerous potential catalysts on it's plate...all looking like they can push sales. Early communications from Biel 2.0 sounds like they are all about moving product. #makethedeals Go Biel$$$
News 
Market Data 
Discover 
